Marie D. Werner, M.D.

Reproductive Endocrinologist at RMA of New Jersey

RMA New Jersey

Marie D. Werner, M.D.


Marie D. Werner, MD, FACOG, HCLD/ALD (ABB) is an attending physician at Reproductive Medicine Associates of New Jersey. Dr. Werner graduated from Boston College with a focus in History and Biochemistry. She then went on to the University of Medicine and Dentistry: New Jersey Medical School where she received her medical degree and was awarded the gold humanism in medicine award. She completed her residency training in Obstetrics and Gynecology at New York University where she was elected as the administrative chief resident. Dr. Werner completed her Reproductive Endocrinology and Infertility fellowship training at Reproductive Medicine Associates of New Jersey (RMANJ) in the Rutgers Robert Wood Johnson fellowship program

Dr. Marie Werner is a board certified Obstetrician Gynecologist, Reproductive endocrinologist and infertility specialist, and board certified High Complexity Lab Director/Andrology Laboratory director in the fields of embryology and andrology. She is the Associate Director for the Reproductive Endocrinology and Infertility Fellowship program at Reproductive Medicine Associates of NJ where she teaches fellows and develops clinical education and research interests.
Dr. Werner received the SRBT Clinical Science Award and the Corporate Member Council In-Training Grant from the American Society for Reproductive Medicine for her research contributions. She serves as an Ad Hoc Reviewer for Fertility and Sterility. Her research interests include ART laboratory science, assessment of embryonic competence and autoimmune disorders and pregnancy.

Read more


BS Boston College (2004)
MD UMDNJ: New Jersey Medical School (2008)
Residency New York University School of Medicine (2012)
Fellowship Rutgers University, Reproductive Medicine Associates of New Jersey (2015)

Honores y reconocimientos

American Society for Reproductive Medicine SRBT Clinical Science Award 2016
American Society for Reproductive Medicine CMC In-Training Travel Award 2015
Midwest Reproductive Symposium Travel Grant 2015
Midwest Reproductive Symposium Southbound Train Grant Award 2014
NYU Chief Resident Teaching Award 2012
NYU Best Senior Resident Teaching Award 2012
Gold Humanism Honor Society 2007
Young Investigators Travel Grant: American Thyroid Association 2006
Alpha Phi Delta Scholarship 2004
National Society of Collegiate Scholars 2002-2004
Phi Alpha Theta, Honors Program in History 2002-2004
Golden Key National Honors Society 2002-2004
National Dean’s List 2002-2004
Boston College Dean’s List 2001-2004


  • Patients with endometriosis have aneuploidy rates equivalent to their age-matched peers in the in vitro fertilization population.
    Juneau C, Kraus E, Werner M, Franasiak J, Morin S, Patounakis G, Molinaro T, de Ziegler D, Scott RT.
    Fertil Steril, 108(2):284-288, 2017.

  • High relative deoxyribonucleic acid content of trophectoderm biopsy adversely affects pregnancy outcomes.
    Neal SA, Franasiak JM, Forman EJ, Werner MD, Morin SJ, Tao X, Treff NR, Scott RT.
    Fertil Steril, 107(3):731-736, 2017.

  • FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles.
    Morin SJ, Tiegs AW, Franasiak JM, Juneau CR, Hong KH, Werner MD, Zhan Y, Landis J, Scott RT.
    Reprod Biomed Online 32(5):496–502, 2016. 

  • Expanded carrier screening in an infertile population: how often is clinical decision making affected?
    Franasiak JM, Olcha M, Bergh PA, Hong KH, Werner MD, Forman EJ, et al.
    Genet Med Off J Am Coll Med Genet 2016.

  • Sequential versus Monophasic Media Impact Trial (SuMMIT): a paired randomized controlled trial comparing a sequential media system to a monophasic medium.
    Werner MD, Hong KH, Franasiak JM, Forman EJ, Reda CV, Molinaro TA, et al.
    Fertil Steril 2016.

  • Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality.
    Green KA, Werner MD, Franasiak JM, Juneau CR, Hong KH, Scott RT.
    J Assist Reprod Genet 2015;32(10):1469–76.

  • Treff NR. 24-chromosome PCR for aneuploidy screening.
    Werner MD, Scott RT.
    Curr Opin Obstet Gynecol. 2015.

  • Endometrial disruption does not improve implantation in patients who have failed the transfer of euploid blastocysts.
    Werner MD, Forman EJ, Hong KH, Franasiak JM, Bergh PA, Scott RT.
    J Assist Reprod Genet 2015.

  • Blastocyst transfer is not associated with increased rates of monozygotic twins when controlling for embryo cohort quality.
    Franasiak JM, Dondik Y, Molinaro TA, Hong KH, Forman EJ, Werner MD, et al.
    Fertil Steril 2015;103(1):95–100.

  • Clinically recognizable error rate after the transfer of comprehensive chromosomal screened euploid embryos is low.
    Werner MD, Leondires MP, Schoolcraft WB, Miller BT, Copperman AB, Robins ED, et al.
    Fertil Steril 2014;102(6):1613–8.

  • Vitamin D levels do not affect IVF outcomes following the transfer of euploid blastocysts.
    Franasiak JM, Molinaro TA, Dubell EK, Scott KL, Ruiz AR, Forman EJ, Werner MD, et al.
    Am J Obstet Gynecol 2015;212(3):315.e1–6.

  • Aneuploidy across individual chromosomes at the embryonic level in trophectoderm biopsies: changes with patient age and chromosome structure.
    Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al.
    J Assist Reprod Genet 2014.

  • Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: a randomized, double-blind, placebo-controlled trial.
    Hong KH, Forman EJ, Werner MD, Upham KM, Gumeny CL, Winslow AD, et al.
    Fertil Steril 2014;102(6):1591–5.e2.

  • Defining the “sweet spot” for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect against a clinically significant late follicular increase in progesterone: an analysis of 10,280 first in vitro fertilization cycles.
    Werner MD, Forman EJ, Hong KH, Franasiak JM, Molinaro TA, Scott RT.
    Fertil Steril 2014;102(5):1312–7.

  • Embryology training for Reproductive Endocrine fellows in the clinical human embryology laboratory.
    Scott RT, Hong KH, Werner MD, Forman EJ, Ruiz A, Cheng MC, et al.
    J Assist Reprod Genet 2014;31(4):385–91.

  • The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening.
    Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al.
    Fertil Steril 2014;101(3):656–663.e1.

  • Extended culture and the risk of preterm delivery in singletons: confounding by indication?
    Forman EJ, Werner MD, Scott RT.
    Hum Reprod. Jul 2013; 28 (7): 2021.

  • Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile population.
    Werner MD, Reh A, Grifo J, Perle MA.
    J Assist Reprod Genet. May 2012. J Assist Reprod Genet. August 2012; 29 (8); 817-20.

  • Laboratory evaluation in oocyte cryopreservation suggests retrieved oocytes are comparable whether frozen for medical indications, deferred reproduction, or oocyte donation.
    Werner MD, Reh A, Labella P, Noyes N.
    J Assist Reprod Genet. Nov 2010; 27 (11); 613-7.

  • Thyroid disease and pregnancy: degrees of knowledge.
    Rinaldi MD, Stagnaro-Green AS.
    Thyroid. Aug 2007; 17(8):747-753.

Read more


Read more
Cerrar menú